Pardes Biosciences
Mandy P's work experience is as follows:
- Board Member at Eledon Pharmaceuticals, Inc. since August 2021.
- Chief Operating Officer and Member of the Corporate Strategy Advisory Board at Pardes Biosciences since August 2021.
- Chief Operating Officer at Neurocrine Biosciences from May 2017 to August 2021.
- Chief Strategy Officer and EVP, Strategy & Business Development at Sanofi from August 2013 to May 2017.
- Principal, Healthcare Investment Banking at Centerview Partners from July 2011 to August 2013.
- Manager, Healthcare Investment Banking at Merrill Lynch from November 2008 to June 2011.
- Consultant, Pharmaceuticals & Medical Products at McKinsey & Company from 2007 to 2008.
Mandy P's education history includes attending Harvard Business School, where they pursued a degree in General Management, specifically an MBA. Prior to that, they attended The Johns Hopkins University School of Medicine, where they pursued a degree in Medicine, specifically a BS. Unfortunately, specific start and end years for both educational experiences are not provided.
This person is not in any teams
Pardes Biosciences
Pardes Biosciences is an agile biopharmaceutical company committed to solving some of the world’s most pressing public health challenges. Pardes leverages structure-based drug design and a tunable, reversible covalent chemistry platform for novel drug discovery.